Cargando…

iTIND: the second-generation temporary implantable nitinol device for minimally invasive treatment of benign prostatic hyperplasia

iTIND is the second-generation version of the temporary nitinol implantable device (TIND), which has emerged over the past decade as one of the latest additions to the library of minimally invasive surgeries now available to treat bothersome lower urinary tract symptoms (LUTS) caused by benign prost...

Descripción completa

Detalles Bibliográficos
Autores principales:	Balakrishnan, Dhivya, Jones, Patrick, Somani, Bhaskar K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328474/ https://www.ncbi.nlm.nih.gov/pubmed/32655690 http://dx.doi.org/10.1177/1756287220934355

Ejemplares similares

Reasons for new MIS. Let's be fair: iTIND, Urolift and Rezūm
por: Suarez-Ibarrola, Rodrigo, et al.
Publicado: (2020)

iTIND for BPH: Technique and procedural outcomes: A narrative review of current literature
por: Fiori, Cristian, et al.
Publicado: (2021)

Caltech RDM by TIND
por: Bjorkoy, Audun
Publicado: (2017)

An Evaluation of Sexual Function in the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia in Men Treated with the Temporarily Implanted Nitinol Device
por: Elterman, Dean, et al.
Publicado: (2022)

Invenio ILS as SaaS @ TIND
por: Bjorkoy, Audun
Publicado: (2017)

Transperineal laser ablation as a new minimally invasive surgical therapy for benign prostatic hyperplasia: a systematic review of existing literature
por: Tzelves, Lazaros, et al.
Publicado: (2023)

Current Applications of Artificial Intelligence in Benign Prostatic Hyperplasia
por: Shah, Milap, et al.
Publicado: (2022)

Emerging Data on the Safety and Efficacy of Transurethral Water Vapour Therapy for Benign Prostatic Hyperplasia
por: Jones, Patrick, et al.
Publicado: (2021)

Update on minimally invasive surgery and benign prostatic hyperplasia
por: Chung, Amanda S.J., et al.
Publicado: (2018)

Minimally Invasive Treatment in Benign Prostatic Hyperplasia (BPH)
por: Sciacqua, L. V., et al.
Publicado: (2023)

Role of Rezum in the treatment of benign prostate hyperplasia: A review of the literature
por: Cocci, Andrea, et al.
Publicado: (2021)

Minimally invasive devices for treating lower urinary tract symptoms in benign prostate hyperplasia: technology update
por: Aoun, Fouad, et al.
Publicado: (2015)

Update on the management of benign prostatic hyperplasia and the role of minimally invasive procedures
por: Franco, Juan V.A., et al.
Publicado: (2023)

Prostatic urethral lift: A minimally invasive treatment for benign prostatic hyperplasia
por: Garcia, Cindy, et al.
Publicado: (2015)

Temporary anchorage devices – Mini-implants
por: Singh, Kamlesh, et al.
Publicado: (2010)

Alexander Nietzold, Co-founder and CEO of TIND, a CERN spin-off.
por: Bennett, Sophia Elizabeth
Publicado: (2016)

Benign Prostatic Hyperplasia
Publicado: (2015)

Minimally invasive simple prostatectomy for a case of giant benign prostatic hyperplasia
por: Zeng, Qin-Song, et al.
Publicado: (2017)

Intraprostatic ozone therapy: A minimally invasive approach in benign prostatic hyperplasia
por: Hussain, Shabbir, et al.
Publicado: (2017)

An Update on Minimally Invasive Surgery for Benign Prostatic Hyperplasia: Techniques, Risks, and Efficacy
por: Srinivasan, Aditya, et al.
Publicado: (2020)

Magnesium-Based Temporary Implants: Potential, Current Status, Applications, and Challenges
por: Seetharaman, Sankaranarayanan, et al.
Publicado: (2023)

Adds-on to legacy for ILS, by Tind.io: loan rules, bibedit, Z39.50
por: LASTECOUERES, Guillaume, et al.
Publicado: (2015)

1-year cost-utility analysis of prostate artery embolization (PAE) versus transurethral resection of the prostate (TURP) in benign prostatic hyperplasia (BPH)
por: Patel, Nikisha, et al.
Publicado: (2021)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

A Novel Nitinol Spherical Occlusion Device for Liver Cancer
por: Hsiao, Hao-Ming, et al.
Publicado: (2016)

Biological Cell Investigation of Structured Nitinol Surfaces for the Functionalization of Implants
por: Hamann, Isabell, et al.
Publicado: (2020)

Functionalization of screw implants with superelastic structured Nitinol anchoring elements
por: Hamann, Isabell, et al.
Publicado: (2022)

Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia
por: Chughtai, Bilal, et al.
Publicado: (2021)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Treatment Algorithm for Management of Benign Prostatic Obstruction: An Overview of Current Techniques
por: Hughes, Thomas, et al.
Publicado: (2023)

Treatment-Induced Neuropathy in Diabetes (TIND)—Developing a Disease Model in Type 1 Diabetic Rats
por: Baum, Petra, et al.
Publicado: (2021)

Effectiveness of a Superelastic Nitinol Device for Fixation of Syndesmosis in Ankle Fracture
por: Ellington, J. Kent, et al.
Publicado: (2022)

Canine prostate models in preclinical studies of minimally invasive interventions: part II, benign prostatic hyperplasia models
por: Sun, Fei, et al.
Publicado: (2017)

Comparison of the Efficacy and Safety of Minimally Invasive Simple Prostatectomy and Endoscopic Enucleation of Prostate for Large Benign Prostatic Hyperplasia
por: Li, Jinze, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eue6aj69unnvs307a9ld5vkf1p